Term
|
Definition
Topical anaesthesia Local infiltration Instillation into a cavity or wound Intravenous regional anaesthesia (Bier’s block) Peripheral nerve blocks Epidural (extradural) block Systemic administration |
|
|
Term
|
Definition
to desensitise mucous membranes (oral, ocular, nasal etc) To desensitise intact skin (EMLA cream) |
|
|
Term
|
Definition
To desensitise dermal and subcutaneous tissues for minor surgery |
|
|
Term
Instillation into a cavity or wound |
|
Definition
Inter-pleural anaesthesia, Intra-articular anaesthesia |
|
|
Term
Intravenous regional anaesthesia |
|
Definition
(Bier’s block) IV administration of lidocaine distal to a tourniquet To desensitise distal limb e.g. digit amputation |
|
|
Term
|
Definition
Used diagnostically & therapeutically Many possibilities e.g. Paravertebral, Intercostal, Brachial Plexus, & dental nerve blocks. |
|
|
Term
Epidural (extradural) block |
|
Definition
To desensitise perineum, hindlimb & caudal abdomen |
|
|
Term
|
Definition
IV infusion of lidocaine in very painful patients |
|
|
Term
|
Definition
Sodium channels are BLOCKED preventing initiation & conduction of action potentials LA’s are weak bases lipophilic aromatic group attached to hydrophilic amine side-chain by ester or amide link |
|
|
Term
|
Definition
[image] rapidly hydrolysed by non-specific cholinesterases short half-lives |
|
|
Term
|
Definition
[image] metabolised in the liver longer half-lives |
|
|
Term
|
Definition
speed of onset related to degree of ionisation duration related to protein-binding potency related to lipid solubility Other drugs may be added: Bicarbonate (increases pH) Adrenaline (vasoconstricts) |
|
|
Term
|
Definition
CNS: initial stimulation leading to convulsions, later depression leading to coma & death CVS: myocardial contractility & heart rate fall, peripheral vasodilation MISC: allergic reactions are rare (ester>amide) methaemoglobinaemia? |
|
|
Term
|
Definition
Management of inflammatory disorders (Osteoarthritis, Ophthalmological disorders e.g. keratitis or uveitis) Management of pain (Acute, Chronic) Management of endotoxaemia in large animals (Equine colic , Bovine toxic mastitis) Management of prothrombotic states (Feline hypertrophic cardiomyopathy) Management of tumours (Some tumours are dependent on COX-2 activity. Piroxicam used to treat transitional cell carcinoma of the urinary bladder) |
|
|
Term
|
Definition
NSAIDs inhibit Cyclooxygenase (COX), which is responsible for the production of prostaglandins and thromboxanes |
|
|
Term
|
Definition
Constitutively expressed in most tissues Involved in normal homeostasis Many physiological functions - especially maintaining GI tract mucosa Up-regulated under stress conditions, e.g. nerve injury |
|
|
Term
|
Definition
Constitutively expressed in many tissues, including kidney, testicular ovarian cells and in the CNS Physiological functions: maintaining renal blood flow, nerve function, bone metabolism ALSO induced in response to inflammatory stimuli |
|
|
Term
|
Definition
Non-selective COX inhibitors (ketoprofen) Preferential COX-2 inhibitor (carprofen, meloxicam) Specific COX-2 inhibitor (firocoxib, robenacoxib) |
|
|
Term
|
Definition
Analgesic - Central/Peripheral Anti-pyretic Anti-inflammatory Anti-thrombotic Anti-endotoxic Other uses(Cancer treatment) |
|
|
Term
Harmful effects of NSAIDs |
|
Definition
Gastrointestinal - Dyspepsia, nausea and vomiting Ulceration Renal toxicity Hepatotoxicity Injury to articular cartilage Precipitate asthma |
|
|
Term
|
Definition
NSAIDs decrease PG production at site of inflammation - reduced sensitisation of nociceptive nerve endings to inflammatory mediators |
|
|
Term
|
Definition
NSAIDs block PG release and neuronal excitation - reduced central sensitisation |
|
|
Term
|
Definition
NSAIDs decrease production of PGE2 (which acts on thermoregulatory centre in hypothalamus) thus prevent increase temperature associated with fever |
|
|
Term
|
Definition
Administration (most well absorbed following oral administration, with food, parenteral formulations also available) Distribution (relatively small Vd – extracellular, highly plasma protein bound (>99%), good penetration into acute inflammatory exudate) Metabolism/excretion (generally by conjugation and renal elimination of metabolites (some biliary elimination) marked interspecies variability) |
|
|
Term
Neuromuscular Blocking drugs |
|
Definition
Neuromuscular Blocking drugs target Nicotinic Acetylcholine receptors Competitive antagonist Nerve impulses blocked Muscle can still respond to direct stimulation |
|
|
Term
|
Definition
Effects: flaccid motor paralysis respiratory muscles last to be affected and first to recover
Unwanted (side) effects: fall in blood pressure: ganglion block / histamine release tachycardia: muscarinic receptor block |
|
|
Term
|
Definition
Mostly quaternary ammonium compounds Administered IV Rate of onset and duration vary Generally metabolised by the liver or excreted unchanged by the kidney Small Volume of Distribution |
|
|
Term
Two Main Groups of NMB Drugs |
|
Definition
Aminosteroids (suffix ‘-onium’) vecuronium, rocuronium, pancuronium, Benzylisoquinolines atracurium, cisatracurium, mivacurium |
|
|
Term
|
Definition
steroid compound devoid of cardiovascular side-effects excreted unchanged in bile |
|
|
Term
|
Definition
fastest onset (<2 min) occasional tachycardia in dogs |
|
|
Term
|
Definition
can release histamine (uncommon in animals) Hofmann elimination: spontaneous degradation at physiological pH and temperature |
|
|
Term
|
Definition
are only administered IV will induce apnoea, so patient must be mechanically ventilated are only administered to anaesthetised patients have no anaesthetic or analgesic effects can be ‘topped up’ or given by IV infusion for as long as required |
|
|
Term
Indications for muscle relaxers |
|
Definition
to facilitate endotracheal intubation to relax skeletal muscle for easier surgical access to control ventilation during anaesthesia ophthalmic surgery |
|
|
Term
|
Definition
eg atropine, glycopyrrolate (Sometimes called anticholinergic drugs) reversals |
|
|
Term
Centrally acting muscle relaxants |
|
Definition
Benzodiazepines diazepam; midazolam
Guaifenesin (glycerol gualacolate, “Gee-Gee”) blocks impulse transmission at internuncial neurones within spinal cord and brain-stem relaxes limb > respiratory muscle mild sedation, no analgesia |
|
|
Term
Modes of delivery for Ectoparasiticides |
|
Definition
Ear tags, tapes, collars for farm animal species Pour on solutions for large and small animals Spot on solutions Collars for cats and dogs Dips for farm animals species Oral tablets or suspensions Sprays |
|
|
Term
|
Definition
target a feature of the parasite that is different from the host. (specific ion channels, metabolism, receptors, proteins) |
|
|
Term
Organophosphates Mechanism of Action |
|
Definition
selective inhibition of acetyl cholinesterase |
|
|
Term
|
Definition
flies, fleas, lice, ticks and mites |
|
|
Term
|
Definition
safely margin is limited for animals and man and these products carry vital operator warnings |
|
|
Term
Pyrethrins and Pyrethroids Mechanism of Action |
|
Definition
on presynaptic sodium channels |
|
|
Term
Pyrethrins and Pyrethroids Spectrum |
|
Definition
|
|
Term
Pyrethrins and Pyrethroids Toxicity |
|
Definition
Low if given orally, fish and some aquatic invertebrates are sensitive. |
|
|
Term
Avermectins and Milbemycins Mechanisn of Action |
|
Definition
Glutamate and/or GABA gated chloride channels |
|
|
Term
Avermectins and Milbemycins Spectrum |
|
Definition
Systemic; sucking lice, some mange mites, warbles |
|
|
Term
Avermectins and Milbemycins Toxicity |
|
Definition
Sensitive animals including some dog species, kittens, some species of birds, turtles, fish and reptiles MDR1 mutation in dogs (shepherds, sheep dogs, collies) |
|
|
Term
Amidines Mechanism of Action |
|
Definition
Octopamine receptor antagonist(behaviour) and alpha2 receptor agonist. Inhibits tick MAO |
|
|
Term
|
Definition
|
|
Term
|
Definition
Transient sedative actions (12-14h after treatment) Some dogs show pruritic symptoms At high exposure: depression and sedation; polyuria; bradycardia; g.i. stasis (horses) Contraindicated in cats, Chihuahuas, dogs in heat stress Treatment: alpha 2 antagonist eg atipamezole, yohimbine |
|
|
Term
Cyromazine and Methoprene Mechanism of Action |
|
Definition
Insect Growth Regulators (IGR). Effect deposition of chitin in cuticle (Cyromazine) and juvenile hormone (Methoprene) |
|
|
Term
Cyromazine and Methoprene Spectrum |
|
Definition
|
|
Term
Benzoyl urea derivative Mechanism of Action |
|
Definition
Inhibits chitin synthase in fleas. Also kills eggs and larvae. |
|
|
Term
Benzoyl urea derivative Spectrum |
|
Definition
|
|
Term
Fipronil Mechanism of Action |
|
Definition
an antagonist to GABA and glutmate gated chloride channels. Greater affinity for insect receptors; reservoir in skin. |
|
|
Term
|
Definition
Fleas, ticks and mites in cats and dogs |
|
|
Term
|
Definition
Toxic to some gallinaceous birds and some fish and aquatic invertebrates |
|
|
Term
Neonicotinoids Mechanism of Action |
|
Definition
Blocks nicotinic receptors. Inhibits cholinergic transmission causing paralysis and death |
|
|
Term
|
Definition
fleas in cats and dogs, rabbits, ferrets |
|
|
Term
|
Definition
|
|
Term
Metaflumizone Mechanism of Action |
|
Definition
Blocks voltage dependant sodium channels resulting in paralysis |
|
|
Term
|
Definition
|
|
Term
Oxadiazine insecticides Mechanism of Action |
|
Definition
Sodium channel blocker (Needs bioactivation) |
|
|
Term
Oxadiazine insecticides Spectrum |
|
Definition
|
|
Term
|
Definition
Organophosphate Paracide 62, Golden fleece sheep dip Cats and dogs: as collars |
|
|
Term
|
Definition
Pyrethroid Advantix for dogs Auriplak tag for cattle Flypor pour on- cattle Xenex spot on small furries |
|
|
Term
Permethrin Toxicity in Cats |
|
Definition
Methocarbamol i.v. (centrally acting muscle relaxant), Seizure control (barbiturates, diazepam, inhalant anaesthetics) |
|
|
Term
|
Definition
Avermectins most commonly used drugs in this class Ivomec: Cattle, sheep, pigs Xeno: spot on small furries and birds (endectocide) Toxicosis syndrome; mydriasis, depression, tremor, ataxia, stupor, emesis, salivation, coma |
|
|
Term
|
Definition
Avermectins Stronghold spot on, dogs and cats |
|
|
Term
|
Definition
Amidines Aludex dogs (POM-V) ProMeris Duo (with Metaflumizone) (POM-V). Treatment of adverse effects: alpha 2 antagonist eg atipamezole, yohimbine |
|
|
Term
|
Definition
Benzoyl urea Derivativ The Program |
|
|
Term
|
Definition
Frontline: cats and dogs (spot on) Frontline Plus: (Plus methoprene) cats and dogs |
|
|
Term
|
Definition
Neonicotinoid Advantage: dogs, cats, rabbits Advantix: (with permethrin) dogs Advocate: (Plus moxidectin) cats, dogs and ferrets |
|
|
Term
|
Definition
ProMeris: cats and dogs. ProMetris Duo (with amitraz) fleas and ticks in dogs |
|
|
Term
|
Definition
Oxadiazine insecticides Activyl tick plus (with permethrin) |
|
|
Term
AntiFungal Drugs Methods of Classifications |
|
Definition
Superficial/Systemic infection Topical/Systemic administration of drug Antifungal antibiotics/ Synthetic agents Fungicidal/Fungistatic Chemical Subclass |
|
|
Term
Anti-Fungal Drugs Chemical Subclassifications |
|
Definition
Antimetabolites Azoles Polyenes Griseofulvin Allylamines Glucan Synthesis inhibitors Other agents |
|
|
Term
Systemic Fungal Infections |
|
Definition
Aspergillus Candida Cryptococcus |
|
|
Term
Superficial Fungal Infections |
|
Definition
Dermatophytes Candida Malessezia |
|
|
Term
Allylamines Mechanism of Action |
|
Definition
inhibits ergosterol biosynthesis via inhibition of squalene epoxidase (FIRST INTERMEDIATE) (fungicidal) |
|
|
Term
|
Definition
|
|
Term
Allylamines Pharmacokinetics |
|
Definition
highly lipophilic (persists in skin), hepatic metabolism, faecal and renal elimination |
|
|
Term
Azoles Mechanism of Action |
|
Definition
inhibits ergosterol biosynthesis via inhibition of cytP450-dependent 14-sterol de-methylase (SECOND INTERMEDIATE) |
|
|
Term
|
Definition
Broad spectrum (generally fungistatic; prolonged treatment) |
|
|
Term
Polyenes Mechanism of Action |
|
Definition
binds to ergosterol, disrupts osmotic integrity of the membrane |
|
|
Term
|
Definition
|
|
Term
Glucan Synthesis Inhibitors Mechanism of Action |
|
Definition
block synthesis of (1,3) glucan which is needed for the cell wall |
|
|
Term
Glucan Synthesis Inhibitors Spectrum |
|
Definition
Candida & Aspergillus Species |
|
|
Term
Anti-metabolites Mechanism of Action |
|
Definition
disrupts protein synthesis (fungicidal) |
|
|
Term
|
Definition
Narrow: Cryptococcus; Candida species |
|
|
Term
Griseofluvin Mechanism of Action |
|
Definition
selectively deposited in newly formed keratin, inhibits mitosis, disorganises the spindle microtubules (fungistatic) |
|
|
Term
|
Definition
Narrow spectrum (all dermatophytes) |
|
|
Term
|
Definition
inhibiting the growth of fungi. |
|
|
Term
|
Definition
|
|
Term
|
Definition
fungi that require keratin for growth. These fungi can cause superficial infections of the skin, hair, and nails |
|
|
Term
|
Definition
Allylamine (specifically Terbinafine) oral and topical highly lipophilic (persists in skin), hepatic metabolism, faecal and renal elimination |
|
|
Term
Ketoconazole and Itraconazole |
|
Definition
Azoles weak bases (needs an acid pH for dissolution), lipophilic, highly plasma protein bound, hepatic metabolism and excretion in faeces |
|
|
Term
|
Definition
Azoles not affected by gastric pH, water soluble and can be given iv, minimally plasma protein bound, minimally metabolised, 80% excreted by kidney unchanged |
|
|
Term
|
Definition
Polyene poorly water soluble, little absorption from GIT |
|
|
Term
|
Definition
Polyene poorly water soluble, little absorption from GIT Spectrum: Yeasts (for otitis externa in dogs and cats) |
|
|